Φορτώνει......
Drugs in early clinical development for Systemic Lupus Erythematosus
INTRODUCTION: While immunosuppressive therapy has positively impacted the prognosis of systemic lupus erythematosus (SLE), many patients still do not respond to traditional therapy. Thus, active SLE disease remains a significant problem. Furthermore, conventional immunosuppressive treatments for SLE...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Opin Investig Drugs |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056793/ https://ncbi.nlm.nih.gov/pubmed/26950689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2016.1162291 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|